Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOWARD: Tocilizumab in RA with inadequate response to DMARDs
NCT00106574Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2005
- Primary completion
- Dec 2007
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 19
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Apr 2005; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00106574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106574.